Cooper Companies (COO) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $13.57B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Albert G. White |
| IPO Date | 1983-01-21 | CAGR | 6.49% |
| Employees | 15,000 | Website | www.coopercos.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.04% | Total Yield | 0.04% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $15.02B | P/E | 15.26 | Forward P/E | 15.28 | PEG | — |
| P/S | 149.51 | P/B | 76.42 | P/CF | 1202.28 | P/FCF | 1944.16 |
| Sales | $4.23B | Sales 1Y | 6.09% | Sales 3Y | 23.45% | Sales 5Y | 59.08% |
| EPS | $4.56 | EPS 1Y | -42.63% | EPS 3Y | -59.86% | EPS 5Y | -97.51% |
| Sales QoQ | 5.6% | EPS QoQ | -160.61% | Sales QoQ Avg | 2% | EPS QoQ Avg | -26.81% |
| Gross Margin | 64.37% | Operating Margin | 11.77% | Profit Margin | 5.57% | ROCE | 4.66% |
| ROA | 2% | ROE | 3% | Altman Z Score | 3.3 | Piotroski Score | 8 |
| Current Ratio | 1.27 | Quick Ratio | 0.78 | Cash Ratio | 0.08 | Op. CF Ratio | -0.14 |
| Debt/Equity | 0.3 | Debt/Assets | 0.2 | Lt Debt/Equity | 0.23 | Lt Debt/Cap. | 0.18 |
| Intrst Cov. | 5.35 | Inventory Turnover | 1.68 | Asset Turnover | 0.34 | Receivables Turnover | 5.23 |
| Enterprise Value | $15.02B | P/E Ratio | 15.26 |
| Forward P/E | 15.28 | PEG Ratio | — |
| P/S Ratio | 149.51 | P/B Ratio | 76.42 |
| P/CF Ratio | 1202.28 | P/FCF Ratio | 1944.16 |
| EPS | $4.56 | EPS Growth 1Y | -42.63% |
| EPS Growth 3Y | -59.86% | EPS Growth 5Y | -97.51% |
| Revenue Growth 1Y | 6.09% | Gross Margin | 0.64% |
| Operating Margin | 0.12% | Profit Margin | 0.06% |
| ROE | 0.03% | ROA | 0.02% |
| ROCE | 0.05% | Current Ratio | 1.27 |
| Quick Ratio | 0.78 | Cash Ratio | 0.08 |
| Debt/Equity | 0.3 | Interest Coverage | 5.35 |
| Altman Z Score | 3.3 | Piotroski Score | 8 |
Cooper Companies (COO) valuation & financials
Cooper Companies (COO) has a market capitalization of $13.57B and trades at a price-to-earnings ratio of 15.3. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Cooper Companies's revenue grew +6.1% over the last year.
Cooper Companies's next earnings report is scheduled for September 9, 2026 after market close; analysts estimate EPS of $1.12. Check the earnings calendar to see all companies reporting this week.
Cooper Companies (COO) — frequently asked questions
When does Cooper Companies (COO) report earnings next?
Cooper Companies is expected to report earnings on September 9, 2026 after market close. Analysts estimate EPS of $1.12.
What is Cooper Companies's market cap?
Cooper Companies (COO) has a market capitalization of $13.57B.
What is COO's P/E ratio?
Cooper Companies trades at a price-to-earnings ratio of 15.3, with trailing twelve-month EPS of $4.56.
How fast is Cooper Companies growing?
Cooper Companies's revenue grew +6.1% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)